The Diskus Inhaler: A Review of its Pharmaceutical and Clinical Performance

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.18, Iss.4, 1999-10, pp. : 287-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Equivalence of a Salmeterol/Fluticasone Propionate Combination Product (50/500µg) Delivered via a Chlorofluorocarbon-Free Metered-Dose Inhaler with the Diskus in Patients with Moderate to Severe Asthma

By van Noord J.A.

Clinical Drug Investigation, Vol. 21, Iss. 4, 2001-04 ,pp. : 243-255

Adis International

Access to resources Recommend Favorite

Fluticasone Propionate via Diskus Inhaler at Half the Microgram Dose of Budesonide via Turbuhaler Inhaler

By Backman R.

Clinical Drug Investigation, Vol. 21, Iss. 11, 2001-11 ,pp. : 735-743

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Salmeterol/Fluticasone Propionate Combination Delivered by the Diskus or Pressurised Metered-Dose Inhaler in Children with Asthma

By Teresa Bracamonte

Clinical Drug Investigation, Vol. 25, Iss. 1, 2005-01 ,pp. : 1-11

Adis International

Access to resources Recommend Favorite

A review of erlotinib and its clinical use

By Tang Patricia A Tsao Ming-Sound Moore Malcolm J

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 2, 2006-02 ,pp. : 177-193

Informa Healthcare

Access to resources Recommend Favorite

Clinical and economic outcomes of pharmaceutical services related to antibiotic use: a literature review

By Gunten Vera Reymond Jean-Philippe Beney Johnny

Pharmacy World and Science, Vol. 29, Iss. 3, 2007-06 ,pp. : 146-163

Springer Publishing Company

Access to resources Recommend Favorite